the Insulin Resistance in Recurrent Miscarriage IN RECURRENT ABORTION

March 13, 2014 updated by: mohamed ahmed selem, Ain Shams University

Insulin Resistance and Recurrent Abortion

THE INSULIN RESISTANCE IN RECURRENT ABORTION

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

THE ROLE OF INSULIN RESISTANCE IN RECURRENT ABORTION

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt
        • Ain Shams Maternity Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 36 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

  1. Women in the child bearing period between 23-40 years.
  2. All patients are pregnant.
  3. The gestational age of both groups 6-13 weeks

Description

Inclusion Criteria:

  1. Women in the child bearing period between 23-40 years.
  2. All patients are pregnant.
  3. The gestational age of both groups 6-13 weeks

Exclusion Criteria:

  1. Patients with gestational diabetes and gestational impaired glucose tolerance.
  2. The patients who took medication that could affect glucose metabolism at the time of the study
  3. Patients with other causes of recurrent abortion as(thyroid dysfunction, uterine anomalies chromosomal abnormalities, antiphspholipid antibody syndrome, uterine anomalies and TORCH syndrome).
  4. Patients with PCOS.
  5. Obese patients(BMI>30)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
group A
cases with recurrent abortion with insulin resisance
Other: insulin resistance(fasting glucose/fasting insulin)
insulin resistance(fasting glucose/fasting insulin )
GROUP B
cases that are pregnant with no history of recurrent abortion with no insulin resistance
Other: insulin resistance(fasting glucose/fasting insulin)
insulin resistance(fasting glucose/fasting insulin )

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
fasting blood glucose
Time Frame: 3 month
Click here for more information about this study: the role of insulin resistance in recurrent abortion
3 month

Secondary Outcome Measures

Outcome Measure
Time Frame
fasting Insulin
Time Frame: 3 month
3 month

Other Outcome Measures

Outcome Measure
Time Frame
oral glucose tolerance test
Time Frame: 3 month
3 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ain Shams University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Anticipated)

November 1, 2014

Study Completion (Anticipated)

April 1, 2015

Study Registration Dates

First Submitted

March 8, 2014

First Submitted That Met QC Criteria

March 13, 2014

First Posted (Estimate)

March 17, 2014

Study Record Updates

Last Update Posted (Estimate)

March 17, 2014

Last Update Submitted That Met QC Criteria

March 13, 2014

Last Verified

March 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • mohd-1978

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Recurrent Abortion

Clinical Trials on insulin resistance(fasting glucose/fasting insulin)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe